Feedback / Questions
ALTO-101 - Alto Neurosci, MEDRx
https://www.businesswire.com/news/home/20251003096029/en/Alto-Neuroscience-Receives-FDA-Fast-Track-Designation-for-ALTO-101-for-the-Treatment-of-Cognitive-Impairment-Associated-with-Schizophrenia
Oct 3, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next